Navigation Links
Americans Optimistic About the War on Cancer

Despite it being the number two killer in our nation, Americans are very optimistic about the war against cancer. In fact, according to a recent nationwide survey sponsored by Abbott, nearly two-thirds (64%) believe the scientific community is winning the war against cancer.

"As an organization researching new options to fight cancer, Abbott is hopeful that its efforts will live up to the optimism expressed by Americans regarding the future of cancer therapy," said John Leonard, M.D., vice president, Global Research and Development, Abbott. "With cancer accounting for nearly 25 percent of all deaths in the United States, we're focused on investigating targeted, less toxic therapies that fill unmet treatment needs."

While most Americans believe that cancer breakthroughs are on the horizon, less than half think a major breakthrough is near. Four out of five (82%) surveyed expect to see new breakthroughs in the next 25 years, but only 42 percent see those breakthroughs occurring in the next decade.

The survey results come just before the American Society of Clinical Oncology (ASCO) Annual Meeting commences in Chicago on June 1. Leading cancer researchers come together each year at the ASCO Annual Meeting to share medical advances and revolutionary approaches to cancer treatment. During the meeting, scientists from independent academic institutions and Abbott will present data on several of Abbott's investigational anti-cancer compounds including a PARP inhibitor (ABT-888) that seeks to enhance the effectiveness of common cancer therapies, a multi-targeted kinase inhibitor (ABT-869) being investigated to suppress tumor growth by cutting off its blood supply and an antimitotic agent (ABT-751) that has shown early promise in the treatment of pediatric neuroblastoma.

In addition, an Abbott scientist will lead an educational session on Abbott's Bcl-2 family protein inhibitors (ABT-263) which restore apoptosis -- the natural process by which damaged or unwanted cells die and are cleared from the body.

According to the survey, Americans also recognize that progress in the fight against cancer is already being made. Four out of five (83%) believe the chances of surviving cancer are better now than they were ten years ago. And almost half (48%) think the chances of survival are "much better" today.

"Abbott has several promising anti-cancer compounds in its oncology pipeline that may prove to be very effective in the fight against cancer," said Stephen Fesik, Ph.D., divisional vice president, Cancer Research, Abbott. "We are committed to exploring new cutting-edge therapies that may enable patients to live longer and healthier lives. Our strategy involves targeting the differences between cancer cells and normal cells and taking away the key fundamental needs of cancer."

More than 1,000 respondents participated in the telephone survey sponsored by Abbott. The goal of the survey was to assess Americans' perceptions of cancer research and their outlook regarding new treatments. Opinion Research Corporation conducted the research.


'"/>




Related medicine news :

1. Poll Finds Many Americans Misinformed About Cancer
2. Poll Finds Many Americans Misinformed About Cancer
3. Hypertension Drug of Choice for African Americans
4. 38 million Americans including 14 million children left to combat hunger
5. Americans Consume Far Too Much Salt and Sodium
6. Americans Growing Out Of Shape
7. Rise in Stress among Americans
8. Home Remedies More Used By Blacks And Native Americans
9. 90 Million Americans Harbor Drug Resistant Bacteria Inside Their Nose
10. Aspirin, Not Used By African Americans And Diabetics To Prevent Heat Problems
11. Americans Not Interested In Choosing Sex Of Child: Survey
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: